SLC6A3 and fragile X-associated tremor/ataxia syndrome: To align our findings with the existing literature in FXTAS and Parkinson’s disease, we began by evaluating dopamine transporter (DAT) levels in the entire striatum and subsequently focused on dopaminergic neurons in the substantia nigra.